INVESTOR RELATIONS
press release – non price-sensitive
26/06/2024
ARTERRA BIOSCIENCE WILL PARTICIPATE IN THE "REVERSE ROADSHOW" EVENT IN NAPLES08/01/2024
PATENT FILED RELATED TO THE USE OF PROPRIETARY LACTOBACILLI AND FLEXIBLE GENETIC TOOLS FOR THE PRODUCTION OF BIOLOGICAL MOLECULES THROUGH…14/09/2023
PROF. DANILO ERCOLINI JOINED ARTERRA BIOSCIENCE AS A MEMBER OF THE SCIENTIFIC TECHNICAL COMMITTEE28/06/2023
ARTERRA BIOSCIENCE IS A CLIMATEPARTNER CERTIFIED COMPANY30/07/2021
SUBMISSION OF A NEW PATENT FOR THE PREVENTION AND TREATMENT OF ATOPIC DERMATITIS05/03/2021
NEW CERTIFICATIONS ISO 14001:2015 (ENVIRONMENT) AND ISO 45001:2018 (HEALTH AND SAFETY AT WORK)07/04/2020
PUBLICATION OF THE CALL FOR THE ORDINARY SHAREHOLDERS’ MEETING24/03/2020
UPDATE REGARDING THE OPERATION OF ARTERRA BIOSCIENCE S.P.A. IN THE LIGHT OF THE DPCM OF MARCH 22, 202013/03/2020
UPDATE REGARDING THE OPERATION OF ARTERRA BIOSCIENCE S.P.A.